Reading Time: 3 minutesA recently published paper, reviewing 15 studies that investigated the effectiveness of riluzole as a treatment for MND in real-time, has suggested that the drug
Search Results for: clinical trial
Reading Time: 4 minutesGuest researcher blog post: My name is Sophie Nyberg and I am a neuroscientist currently working in the Lighthouse COVID-19 testing labs in Alderley Park,
Reading Time: 5 minutesLast Thursday marked an exciting milestone in the search for effective therapies for MND as full results from the early-phase 1/2 trial of Biogen’s tofersen
Reading Time: 4 minutesAlthough ALS is a neurodegenerative disease, researchers are increasingly also interested in events happening outside the brain and spinal cord, in particular whether changes in
Reading Time: 2 minutesGuest researcher blog post written by Elisabeth Jirström: Hi! My name is Elisabeth Jirström and I am a PhD student at Royal College of Surgeons
Reading Time: 3 minutesGuest researcher blog post written by Liam Knox: My name is Liam Knox and I am a Postdoctoral Research Associate who has recently joined Dr
Reading Time: 5 minutesSoon after 8 medical students at the University of Southampton volunteered for the Motor Neurone Disease Association (with their local Southampton and Winchester branch) and
Reading Time: 6 minutesToday marks 10 years since the MND Association’s research blog first started, making it our ‘blogiversary’. It officially began with a welcome post from our
Reading Time: 5 minutesOn top of all the sharing of research and networking, the International Symposium is a time to celebrate the huge achievements of individuals/teams that contribute
Reading Time: 4 minutesThis week sees the start of the 30th International Symposium on ALS/MND in Perth, Australia. The Symposium brings together the brightest minds from the MND